Cargando…
The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we use...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408640/ https://www.ncbi.nlm.nih.gov/pubmed/30881401 http://dx.doi.org/10.12669/pjms.35.1.415 |
_version_ | 1783401808295624704 |
---|---|
author | Yildirim, Rahsan Sincan, Gulden |
author_facet | Yildirim, Rahsan Sincan, Gulden |
author_sort | Yildirim, Rahsan |
collection | PubMed |
description | OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we used T test for comparison of groups. We evaluated the parameters affecting surveillance with cox regression analysis. RESULTS: The most common histological types of nonhodgkins lymphoma was diffuse large b cell lymphoma (n: 63, 78.75%). Thirty-nine percent of all patients had anemia, 32% had hypoalbunemia, 71.25% had elevated serum LDH, 32.5% had elevated serum ß2 microglobulin value. Advanced age, the presence of bulky disease, elevated Ki-67 level, IPI score, refractory to first line treatment were found to be correlated with shorter survival time. We treated 77 (96.25%) patients with doxorubicin containing regimen. Complete and partial remission rates of first line treatment were 77.5% and 10%, respectively. Seven (8.75%) patients died because of disease progression and 1 (1.25%) patient died due to sepsis. CONCLUSION: The frequency of lymphoma subtypes, clinical characteristics, treatment outcomes and survival rate vary from region to region. Therefore it is important to determine dissimilarity of these parameters for improve of survey. |
format | Online Article Text |
id | pubmed-6408640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Professional Medical Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-64086402019-03-15 The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey Yildirim, Rahsan Sincan, Gulden Pak J Med Sci Original Article OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we used T test for comparison of groups. We evaluated the parameters affecting surveillance with cox regression analysis. RESULTS: The most common histological types of nonhodgkins lymphoma was diffuse large b cell lymphoma (n: 63, 78.75%). Thirty-nine percent of all patients had anemia, 32% had hypoalbunemia, 71.25% had elevated serum LDH, 32.5% had elevated serum ß2 microglobulin value. Advanced age, the presence of bulky disease, elevated Ki-67 level, IPI score, refractory to first line treatment were found to be correlated with shorter survival time. We treated 77 (96.25%) patients with doxorubicin containing regimen. Complete and partial remission rates of first line treatment were 77.5% and 10%, respectively. Seven (8.75%) patients died because of disease progression and 1 (1.25%) patient died due to sepsis. CONCLUSION: The frequency of lymphoma subtypes, clinical characteristics, treatment outcomes and survival rate vary from region to region. Therefore it is important to determine dissimilarity of these parameters for improve of survey. Professional Medical Publications 2019 /pmc/articles/PMC6408640/ /pubmed/30881401 http://dx.doi.org/10.12669/pjms.35.1.415 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yildirim, Rahsan Sincan, Gulden The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title | The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title_full | The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title_fullStr | The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title_full_unstemmed | The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title_short | The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey |
title_sort | clinicopathologic features and response to treatment of patients with nonhodgkin lymphoma: a single-center experiment in turkey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408640/ https://www.ncbi.nlm.nih.gov/pubmed/30881401 http://dx.doi.org/10.12669/pjms.35.1.415 |
work_keys_str_mv | AT yildirimrahsan theclinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey AT sincangulden theclinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey AT yildirimrahsan clinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey AT sincangulden clinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey |